Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2008
10/16/2008US20080254050 Immunotherapeutic comprising very small particles from neisserial outer memebrane protein and/or vascular endothelial growth factor for use in targeting a nd treating cell proliferative, inflammatory autoimmune and vision defects
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254047 Activation of Human Antigen-Presenting Cells Through CLEC-6
10/16/2008US20080254046 Method for the Delivery of Exogenous Antigens into the Mhc Class I Presentation Pathway of Cells
10/16/2008US20080254045 Therapeutic mixture comprising a non-specific cluster of differentiation-1 (CD1d) complex which comprises beta 2-microglobulin and binds ceramide-like glycolipid antigens for use in treatment of autoimmune disorders
10/16/2008US20080254039 Prevention of Thrombus Formation and/or Stabilization
10/16/2008US20080254030 Using B cell survival factor (BAFF) agonist as therapeutic in treatment of asthma
10/16/2008US20080254029 Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders
10/16/2008US20080254025 Using interleukin-1( IL-1) specific immunoglobulin for diagnosis, prevention and treatment of osteoarthritic, inflammatory, respiratory and autoimmune disorders
10/16/2008US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
10/16/2008US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals
10/16/2008CA2683453A1 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1980268A2 Vaccination methods against avian influenza virus
10/15/2008EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
10/15/2008EP1979346A1 Thiazole derivatives and use thereof
10/15/2008EP1979345A2 Novel pyridine derivatives
10/15/2008EP1979335A2 Thiazoles as 11 beta-hsd1 inhibitors
10/15/2008EP1979316A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
10/15/2008EP1978980A1 Use of a combination of ethanolic rosa sp . , urtica dioica and tanacetum vulgare extracts, further comprising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections
10/15/2008EP1776366B1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1641771B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/15/2008EP1490069B1 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1411982B1 Modulators of p-selectin glycoprotein ligand 1
10/15/2008EP1387670B1 Immune modulation device for use in animals
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1372704B1 Monocyte-specific particulate delivery vehicle
10/15/2008EP1319008B1 Water soluble rapamycin esters
10/15/2008EP1311658B1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP1107785B1 Method of dna vaccination
10/15/2008CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target
10/15/2008CN101287736A Pyrrolopyrimidine derivatives as SYK inhibitors
10/15/2008CN101287716A Aminodiazepines as toll-like receptor modulators
10/15/2008CN101287487A Agents and methods based on the use of the EDA domain of fibronectin
10/15/2008CN101287465A Use of bipyridine compound 'caerulomycin A' derivatives and analogs thereof as immunosuppressive agents
10/15/2008CN101284871A Cyclic peptides with ¿CPro-Sta-Tyr- residue fragment as immunity inhibitor and synthesis process thereof
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284820A Amino peptidase inhibiting substance and synthetic method
10/15/2008CN101284818A Solid forms of (E) -1- (4- ( (1R, 2S, 3R) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/15/2008CN101284115A Kidney-tonifying and body-strengthening pellet and production technique thereof
10/15/2008CN101284061A Chinese herbal medicine formulations for promoting the yellow catfish growing
10/15/2008CN101284041A Compound radix astragali Chinese medicinal formulations with health-care function and preparation technique
10/15/2008CN101284040A Complex immunity strengthening agent for crabeater young fish
10/15/2008CN101284033A Chinese medicinal composition containing Fructus choerospondiatis and its preparation method and application
10/15/2008CN101284026A Chinese medicinal composition for treating skin hypersensitivity disease
10/15/2008CN101284006A Medicine composition for treating eye disease
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283987A Chloroquine liposomes freeze-dried powder injection and preparation method thereof
10/15/2008CN101283985A Enteric oral vaccine for fishing gear and preparation method thereof
10/15/2008CN101283807A PUFA supplements
10/15/2008CN101283721A Concentrated coffee pulp
10/15/2008CN101283715A Health-care beverage health preservation tea
10/15/2008CN100425697C Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
10/15/2008CN100425692C Method for preparing rabbitpox culturing tissue containing high-quality physiological activity
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425237C Compound cetirizine hydrochloride gel
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury
10/14/2008US7435801 Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008US7435585 Auto-stimulating cells and methods for making and using the same
10/14/2008US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents
10/14/2008US7435421 Derivatives of choline binding proteins for vaccines
10/14/2008US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2338680C Medicinal aerosol formulations
10/14/2008CA2288821C Modulation of human mast cell activation
10/14/2008CA2237529C Vaccine compositions for intranasal administration comprising chitosan and use thereof
10/14/2008CA2168584C A method for sensitization of cancer cells for killer cell mediated lysis
10/10/2008CA2585035A1 Composition for enhancing immunity and reducing inflammation related to infections
10/10/2008CA2585034A1 Composition for improving immune system health
10/09/2008WO2008121027A1 Growth stimulating and cell regenerating composition and a method for carrying out said method
10/09/2008WO2008121019A1 Antihistaminic and antiallergic agent and a method for the production thereof.
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120617A1 Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease
10/09/2008WO2008119792A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008WO2008119534A1 Production of a viable, storable worm egg suspension
10/09/2008WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
10/09/2008WO2008119185A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008WO2008100622A3 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/09/2008WO2008081111A8 OLIGO-β(1→3)-GLUCANES HAVING AN ALLERGIC-REACTION INHIBITING EFFECT AND APPLICATIONS THEREOF
10/09/2008WO2008079521A3 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 1172